Zenuzolac clinical trials
Also written VGX-1027.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How each study uses zenuzolac is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
VGX Pharmaceuticals, LLC (2) · GeneOne Life Science, Inc. (1)
Studies
Open first, then newest update. How each study uses zenuzolac is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)CompletedPhase 2GeneOne Life Science, Inc.NCT04590547Written as GLS-1027How we know
- Multiple-Dose Study of VGX-1027 in Healthy SubjectsCompletedPhase 1VGX Pharmaceuticals, LLCNCT00760396Written as VGX-1027How we know
- Phase I Safety and Pharmacokinetic Study of VGX-1027 in Healthy SubjectsCompletedPhase 1VGX Pharmaceuticals, LLCNCT00627120Written as VGX-1027How we know
Codes
What other systems call zenuzolac · ClinicalTrials.gg INT005065
- UNII (FDA) AKT814N13RZENUZOLACOne source FDA
- NCI Thesaurus C184883ZenuzolacOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | AKT814N13R | ZENUZOLAC | One source FDA |
| NCI Thesaurus | C184883 | Zenuzolac | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.